Happtique Announces Medical App Certification
The number of medical apps has increased dramatically in the past two to three years and until now there has been little to no formal review process. This could soon be changing, as private firm Happtique has published certification standards and announced review boards to help hospitals and consumers cut through the crowded medical, health and fitness app marketplace.
Happtique aims to benchmark apps within the healthcare industry and remove ‘anything goes’ mentality that currently exists. There is such a vast number of apps on the market leading consumers and hospitals in doubt over which ones to use. Until now there has been no official help or certification.
App developers that want to reach the certification standards will have to submit an application and partake in a review process. The voluntary program will be open to all app developers and will be funded by developer application fees, which will cost between $2,000 and $3,000. Although developers can fill out certification forms now, they won’t actually be able to submit applications until the certification portal opens in late spring. The goal is to evaluate apps on a pass/fail basis in 30 days or less.
The development comes one year after Happtique submitted draft guidelines for public comment. The standards evaluate operability, privacy, security and content. There are also performance requirements. Although it received input from regulators like the US Food and Drug Administration and the Federal Trade Commission, and the Office of the National Coordinator for Health Information Technology, they did not formally endorse or approve the certification requirements.
In a phone interview with MedCity News, Ben Chodor, Happtique CEO, said as the mobile health industry has evolved it was time that app developers became more accountable for their products to ensure they are safe to use. He said the regulatory nature of the healthcare industry justified the certification fee.
“If you are not going to make the commitment to contribute a few thousand dollars for an app that will be used by patients and clinicians then you’d probably think twice about going into a heavily regulated industry. We want every developer to wear that certification badge proudly on their websites.”
Chodor added that since the development of the certification standards began he has seen a lot more apps for interoperability come into the market, particularly for electronic medical records.
The company has also enlisted the help of the Association of American Medical Colleges, which will conduct the content evaluation for apps related to medical and patient education. It is the largest association representing accredited medical schools in the US, and also represents roughly 400 teaching hospitals as well as medical societies. CGFNS International does credentials evaluation for nurses and other health care professionals. Intertek – a testing and certification group — will evaluate the performance of the apps.
Intertek, AAMC and CGFNS are Health App Certification Partners who will evaluate the health apps against the certification standards. Other partners will be added to evaluate apps specific to specialties like cardiology and endocrinology, Chodor added.
Happtique says its standards will help providers and consumers identify apps that deliver credible content, contain safeguards for user data and function, according to a company statement.
Lee Perlman, president of GNYHA Ventures and managing director of Happtique, said in the statement the certification standards will complement the objectives of federal agencies involved in the regulation of mobile health apps.
Depending on how widely adopted the certification process becomes, it could shape the options of app developers. It will give street cred and access to those apps that pass muster and a two year certification for the app(s) submitted. For those that don’t, they may have to focus on the consumer markets. It may truly raise the bar. Just as important, it may go some way to raise the esteem of apps in the eyes of sceptics.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”